Xuefei Wang

8PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersMolecular targetsDisease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 15, 2026
Intratumoral PD-1+LAG-3+CD8+ T cells are associated with improved prognosis in gastric cancer.

|Mar 09, 2026
Hyaluronic acid-CD44 signaling defines therapeutic resistance and immunosuppressive microenvironment in peritoneal metastasis of gastric cancer.

Junjie Zhao, Chengbo Ji, Jie Sun

|Dec 18, 2025
Proteasome stress activates YAP/TAZ through the RAP2-MAP4Ks-LATS1/2 pathway and its therapeutic implications in solid tumors.

Xin Wang, Yuan Gu, Zhenxing Zhong

|Aug 26, 2025
Aberrant PJA2-CHRM3 signaling creates a therapeutic vulnerability in gastric tumor.

Lingmeng Li, Jingyi Yin, Ling Zhang

|Feb 19, 2024
DeepRisk network: an AI-based tool for digital pathology signature and treatment responsiveness of gastric cancer using whole-slide images.

Mengxin Tian, Zhao Yao, Yufu Zhou

|Nov 10, 2022
The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction.

Zhaoqing Tang, Yan Wang, Dan Liu

Pageof 2

Frequent Collaborators

2 joint publications

Liyu Huang

1 joint publications

Yuanyuan Ruan

1 joint publications

Zhaoqing Tang

1 joint publications

Chen Xu